StockMarketWire.com - Verona Pharma has narrowed its FY pretax loss to £5.97m, from a year-ago restated loss of £9.0m. Most of the losses were linked to R&D and general & administrative costs.




At 9:45am: [LON:VRP] Verona Pharma PLC share price was +10.5p at 141.5p



Story provided by StockMarketWire.com